The GLP-1 Outlook: From Drug Pipeline to Consumer Behavior Impacts

Join Bloomberg for a comprehensive discussion on the evolving GLP-1 landscape and its far-reaching implications across both healthcare and the broader consumer economy. As anti-obesity therapies transform not only pharmaceutical markets but also consumer spending, understanding the full picture requires more than traditional market intelligence. In this webinar, we'll demonstrate how Bloomberg's research, insights, and alternative data can be used to track the GLP-1 ecosystem, from obesity market expectations and the growth of the cash-pay market to shifting consumer behavior and spending trends. Join us for an interactive demonstration and discussion on how these insights can help investors and corporate decision-makers identify opportunities and risks across healthcare, consumer, and adjacent sectors.